Is Digoxin Still Justifiable As Single First-Line Therapy In Fetal Svt Associated With Fetal Hydrops?
GEBURTSHILFE UND FRAUENHEILKUNDE(2008)
摘要
As long as there is no unanimity in the approach to the drug treatment of fetal tachycardia, digoxin continues to be the most commonly used first-line antiarrhythmic drug. Flecainide, sotalol and amiodarone have emerged as effective second-line treatment after digoxin failure both in nonhydropic and hydropic fetuses.
更多查看译文
关键词
fetal hydrops,fetal svt,digoxin,first-line
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要